Global Blood Therapeutics Inc - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of Global Blood Therapeutics Inc can be accessed by signing up for free. Scroll down to the end of this webpage for potential risks for Global Blood Therapeutics Inc based on sector, geography and marketcap. If you are employed by Global Blood Therapeutics Inc and you would like to licence your Sustainability aseessment, please contact us.
Global Blood Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.5; made up of an environmental score of 1.3, social score of 3.4 and governance score of 2.7.
2.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1481 | Tissue Regenix Group PLC | 2.6 | Medium |
| 1481 | Twist Bioscience Corp | 2.6 | Medium |
| 1499 | Global Blood Therapeutics Inc | 2.5 | Medium |
| 1499 | Akeso Inc | 2.5 | Medium |
| 1499 | Allergan plc | 2.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Global Blood Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Global Blood Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Global Blood Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Global Blood Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Global Blood Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Global Blood Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Global Blood Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Global Blood Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Global Blood Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Global Blood Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Global Blood Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Global Blood Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Global Blood Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Global Blood Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Global Blood Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Global Blood Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Global Blood Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Global Blood Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.